NDC 0025-1011
ALDACTAZIDE
Spironolactone And Hydrochlorothiazide
ALDACTAZIDE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by G.d. Searle Llc Division Of Pfizer Inc. The primary component is Spironolactone; Hydrochlorothiazide.
| Product ID | 0025-1011_21efa415-8c89-4298-961d-2b3ec11ed531 |
| NDC | 0025-1011 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ALDACTAZIDE |
| Generic Name | Spironolactone And Hydrochlorothiazide |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1978-01-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA012616 |
| Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
| Substance Name | SPIRONOLACTONE; HYDROCHLOROTHIAZIDE |
| Active Ingredient Strength | 25 mg/1; mg/1 |
| Pharm Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 0025-1011-31
100 TABLET, FILM COATED in 1 BOTTLE (0025-1011-31)
| Marketing Start Date | 1978-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0025-1011-55 [00025101155]
ALDACTAZIDE TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA012616 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1978-01-01 |
| Marketing End Date | 2011-05-13 |
NDC 0025-1011-31 [00025101131]
ALDACTAZIDE TABLET, FILM COATED
| Marketing Category | NDA |
| Application Number | NDA012616 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1978-01-01 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| SPIRONOLACTONE | 25 mg/1 |
OpenFDA Data
| SPL SET ID: | d44637a7-b980-4bb1-832c-f5a0f73f8259 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- Aldosterone Antagonist [EPC]
- Aldosterone Antagonists [MoA]
- Increased Diuresis [PE]
- Thiazide Diuretic [EPC]
- Thiazides [CS]
- Aldosterone Antagonist [EPC]
- Aldosterone Antagonists [MoA]
- Increased Diuresis [PE]
- Thiazide Diuretic [EPC]
- Thiazides [CS]
NDC Crossover Matching brand name "ALDACTAZIDE" or generic name "Spironolactone And Hydrochlorothiazide"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0025-1011 | ALDACTAZIDE | spironolactone and hydrochlorothiazide |
| 0025-1021 | ALDACTAZIDE | spironolactone and hydrochlorothiazide |
| 0378-0141 | Spironolactone and Hydrochlorothiazide | spironolactone and hydrochlorothiazide |
| 0378-0403 | Spironolactone and Hydrochlorothiazide | spironolactone and hydrochlorothiazide |
| 42292-017 | Spironolactone and Hydrochlorothiazide | spironolactone and hydrochlorothiazide |
| 53489-144 | Spironolactone and Hydrochlorothiazide | Spironolactone and Hydrochlorothiazide |
| 59762-5014 | Spironolactone and Hydrochlorothiazide | spironolactone and hydrochlorothiazide |
| 63629-1068 | Spironolactone and Hydrochlorothiazide | Spironolactone and Hydrochlorothiazide |
| 63629-1069 | Spironolactone and Hydrochlorothiazide | Spironolactone and Hydrochlorothiazide |
| 63629-1071 | Spironolactone and Hydrochlorothiazide | Spironolactone and Hydrochlorothiazide |
| 66993-188 | Spironolactone and Hydrochlorothiazide | spironolactone and hydrochlorothiazide |
Trademark Results [ALDACTAZIDE]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 ALDACTAZIDE 72093367 0706217 Live/Registered |
G. D. Searle & Co. 1960-03-21 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.